PFAS Testing and Compliance in New York
New York has shifted from reactive-response mode to a broad, long-term PFAS strategy that spans drinking water, private wells, soils, wastewater, biosolids, consumer products, and more. This page is designed for New York utilities, POTWs, industrial and commercial facilities, municipalities, property owners, and consumer brands that need to understand how PFAS regulations affect their testing and compliance obligations. For these groups, the state’s approach means more comprehensive testing, stricter cleanup expectations, and expanding product restrictions.

New York's PFAS approach combines a decade of foundational work with a wave of new and proposed actions that will shape compliance for years to come.
In 2017, New York designated PFOA and PFOS as hazardous substances, bringing them fully under state cleanup programs and liability frameworks. This classification means PFAS must be evaluated at sites with known or suspected contamination, alongside more traditional contaminants. It also gives regulators clearer authority to compel investigation and remediation when PFAS are detected in soil or groundwater. For responsible parties, that translates into earlier PFAS screening and potentially broader corrective actions at existing and new sites.
New York's current Maximum Contaminant Limits (MCLs) of 10 ppt for PFOA and PFOS in public drinking water systems set a high bar for protection. Systems exceeding these levels must investigate sources and implement corrective actions, often including advanced treatment technologies.
In 2025, the New York legislature proposed lowering New York’s enforceable PFAS limits (Senate Bill S3207A) to 4 ppt for PFOA and PFOS and 10 ppt for PFNA, PFHxS, and HFPO-DA, closely mirroring the U.S. EPA’s 2024 PFAS National Primary Drinking Water Regulations (NPDWR).
A pilot program has been proposed to support PFAS testing and treatment for private wells in New York communities with elevated PFAS detections, coupled with proposed updates to the state’s Assistance for Contaminated Water Supplies guidance. The draft framework clarifies how the state defines areas of concern, interprets well sample results, and decides when to provide alternate water supplies such as bottled water or point-of-entry treatment.
This approach recognizes that PFAS in private wells may stem from a variety of sources, such as septic systems, wastewater, or biosolids. For local governments and consultants, it creates clearer expectations around when state support may be available and how to document the impact of PFAS on private wells.
New York prohibited intentionally added PFAS in most apparel as of 2025. DEC must set a PFAS threshold for all apparel by January 1, 2027, and outdoor apparel for severe wet conditions must be PFAS-free by January 1, 2028 (with earlier disclosure requirements). Proposed legislation, such as Assembly Bill A7738, would expand these controls to a broad set of “covered products,” relying on total organic fluorine (TOF) thresholds to identify regulated PFAS content.
This shift from banning specific PFAS compounds toward TOF makes analytical strategy and supply-chain documentation more complex, especially for brands that source materials from a variety of vendors. Companies selling into New York may require screening tools and targeted methods to demonstrate compliance and to manage reformulation efforts.
DEC’s technical guidance for Publicly Owned Treatment Works (POTWs) establishes expectations for PFAS monitoring in influent, effluent, and sometimes biosolids, with an emphasis on plants located in drinking-water watersheds or that recycle biosolids.
Draft “PFAS Discharge Disclosure Act” bills (S4574A/A5832A) would further require certain State Pollutant Discharge Elimination System (SPDES) permit holders to monitor for PFAS discharges, report results, and in some cases, submit projected PFAS loads with new permit applications. These measures encourage POTWs to identify and manage significant industrial sources, often through pretreatment or best-management practices. Industrial dischargers, in turn, will need to better understand how their processes may impact PFAS in wastewater effluent and stormwater runoff.
Pace® provides the technical expertise, validated methods, and regulatory insight needed to help New York organizations understand, monitor, and manage PFAS in alignment with state and federal requirements.
Pace® operates several New York ELAP-accredited laboratories, in-state and throughout the area, with the expertise to help New York public water systems and facilities meet current and emerging PFAS drinking water standards. Our labs perform PFAS analyses using EPA-validated drinking water methods EPA 533 and EPA 537.1. We also offer EPA 1633A and ASTM D8421 for non-potable source water investigation and compliance. Pace® laboratory data packages and reporting formats support New York Department of Health (DOH) and EPA drinking water compliance documentation.
For private wells, Pace® offers PFAS testing panels that use the same EPA drinking water methods applied to public supplies. These services include guidance on sampling, assistance in interpreting results, and support in identifying follow-up treatment options for community investigations, small systems, property owners, and consultants dealing with PFAS in private wells.
Pace® provides PFAS testing for wastewater and stormwater in New York using accredited laboratories and advanced LC-MS/MS methods designed for complex, non-potable matrices. These services cover influent and effluent from POTWs and industrial dischargers, as well as stormwater runoff, landfill leachate, and related process waters, supporting compliance with state and federal PFAS monitoring and permitting expectations. PFAS data packages are formatted to support SPDES permit applications and local pretreatment program decisions, giving utilities and industrial facilities defensible information for both permitting and source-control planning.
Pace® provides PFAS compound-specific testing for New York consumer products as well as organic fluorine methods. These services cover cosmetics, textiles, food-contact materials, packaging, and other finished goods, allowing manufacturers and retailers to identify individual PFAS, verify “PFAS-free” claims, and compare results to internal specifications or regulatory thresholds. By characterizing PFAS content in products and raw materials, our New York clients are better prepared to comply with existing and emerging state restrictions and disclosure laws on PFAS in consumer products and related articles.
Pace® provides PFAS-focused environmental site assessment (ESA) sampling and analytical services in New York for soil, groundwater, surface water, sediment, landfill leachate, biosolids, biota, and building or product materials, helping consultants and property owners understand PFAS contamination and evaluate remediation options. Our data packages and QA/QC protocols are designed to meet the defensibility expectations of CERCLA and state Superfund programs, supporting PFAS site characterization, remedy selection, and long-term stewardship.
In addition to PFAS, our testing portfolio includes a full suite of contaminants—such as VOCs, SVOCs, metals, petroleum hydrocarbons, and emerging contaminants—so investigation teams can address ESA and CERCLA-driven data needs from initial screening through long-term monitoring and remedial performance evaluation.
PFAS Treatability Studies help New York utilities, industries, consultants, and site owners evaluate how well different technologies remove, concentrate, or destroy PFAS in drinking water, wastewater, leachate, and other environmental media. By generating performance data under site-specific conditions, these studies support the selection and optimization of treatment systems, demonstrate effectiveness to regulators and stakeholders, and reduce risk before full-scale investments in PFAS remediation or destruction projects.
Learn more about PFAS Treatability Studies
Watch: Navigating PFAS in Drinking Water: Treatability Insights and Analytical Overview


Pace® offers comprehensive, state-of-the-art PFAS testing in New York, combining advanced analytical methods with deep regulatory expertise to deliver fast, defensible results for drinking water, wastewater, soil, and other environmental matrices. With a robust network of certified laboratories, dedicated project management, and rigorous quality assurance, Pace® helps public agencies, utilities, and private clients meet evolving state and federal PFAS requirements while minimizing risk and maintaining compliance.
Yes, PFAS have been detected in some New York public drinking water systems, but levels vary by location and system. Several sources give New Yorkers insight into PFAS in public drinking water systems. The U.S. EPA’s Fifth Unregulated Contaminant Monitoring Rule (UCMR 5) required thousands of public water systems nationwide to test for 29 PFAS plus lithium between 2023 and 2025. The results are publicly available through the UCMR 5 data finder, which lets users drill down by state and then by individual water system.
New York State DEC also provides information on PFAS and 1,4-dioxane through its Division of Water PFAS information portal and related webpages, which summarize state monitoring, regulatory actions, and links to additional water-quality data for New York systems. Pace® collaborates with the New York State DEC as an approved contractor to support these monitoring and reporting efforts.

Rural areas of New York are impacted by PFAS. New York’s Rural Soil Background Study shows that PFAS are present even in remote, non-industrial parts of the state. PFOS was detected in more than 97% of surface soil samples collected from rural properties, and PFOA was detected in about 76.5% of samples. The study found no clear geographic clustering or patterns that would point to specific local sources, indicating that low-level PFAS contamination is widespread across rural landscapes rather than limited to heavily developed or industrial areas.
You should consider having your private well tested if there are known or suspected contamination sources nearby, such as industrial sites, firefighting foam use, or landfills. If in doubt, private well owners can use the UCMR 5 data finder and the New York Division of Water PFAS information portal to determine the prevalence of PFAS in drinking water in their area. If PFAS has been detected in nearby public water systems, it is likely to be found in local private wells, as they often use the same or connected source waters.
New York does not currently regulate PFAS in private wells, but state agencies advise using public drinking water standards as a health-based benchmark and encourage owners to test periodically for common contaminants and PFAS to determine whether treatment or an alternate water source is needed. If enacted, recent proposals to provide grants or rebates for PFAS treatment may require documented test results showing PFAS above specified thresholds in the private well.


Elevated Levels of PFAS in drinking water are typically treated using advanced treatment technologies that remove PFAS from the water before it reaches consumers. The main options identified by the U.S. EPA as best available technologies (BAT) are granular activated carbon (GAC), anion-exchange resins, and high-pressure membrane systems such as reverse osmosis or nanofiltration. These processes adsorb or collect PFAS so utilities or homeowners can meet health-based standards.
New York Law §37-0121 defines PFAS as “a class of fluorinated organic chemicals containing at least one fully fluorinated carbon atom.”
This definition aligns with the broad, structure-based definition used in other New York provisions that reference PFAS.


By measuring the total amount of organically bound fluorine in a sample, TOF analysis tells you whether a product likely contains fluorinated chemicals, including PFAS, and at roughly what concentration. Because all PFAS contain at least one carbon-fluorine bond, TOF results can flag products or materials that may warrant more detailed, compound-specific PFAS analysis or supply-chain review.


TOF analysis has a couple of critical limitations as an indicator of PFAS content in a product:
TOF does not identify which PFAS (or other organic fluorinated chemicals) are present or quantify individual PFAS.
TOF results can also be influenced by non-PFAS compounds, such as certain pharmaceuticals or other fluorinated additives, so a high TOF result does not automatically mean PFAS are present.
TOF methods also tend to have higher detection limits (often at the ppm level) than targeted LC-MS/MS PFAS methods, making them less suitable for demonstrating compliance with low-level regulatory limits and better suited as a screening or complementary tool.
For more downloadable resources, visit our resources page.
US EPA Information Collection Rule (ICR) Proposal for PFAS and NPDES
EPA PFAS Test Methods Are Now Final, What That Means for Wastewater and Solid Waste Professionals
Quantifying PFAS in Consumer and Related Products: The Latest Developments
Unlock PFAS Maximum Contaminant Levels (MCLs) Insights – What, When, How
Navigating the Complexities of Testing for PFAS in Plant and Animal Tissue
Navigating PFAS in Drinking Water: Treatability Insights and Analytical Overview
COREDFN: A High-Resolution Approach to Bedrock Investigations Involving VOCs and PFAS